Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study.

BMJ (Clinical research ed.) - 12 Apr 2008

Finning Kirstin, Martin Pete, Summers Joanna, Massey Edwin, Poole Geoff, Daniels Geoff

Abstract excerpt

OBJECTIVES: To assess the feasibility of applying a high throughput method, with an automated robotic technique, for predicting fetal RhD phenotype from fetal DNA in the plasma of RhD negative pregnant women to avoid unnecessary treatment with anti-RhD immunoglobulin. DESIGN: Prospective comparison of fetal RHD genotype determined from fetal DNA in maternal plasma with the serologically determined fetal RhD...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Feasibility Studies
Share to Fetal Blood

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fetal Diseases

Share to Genetic Techniques

Share to Gestational Age

Share to Rh Isoimmunization

Share to Rho(D) Immune Globulin

Share to Sensitivity and Specificity

Source

Open in PubMed Open full text

Identifiers

PMID: 18390496
DOI: 10.1136/bmj.39518.463206.25
PMCID: PMC2292334

Genes

RHD

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study.PMID 18390496Read ↗

Fetal RHD genotyping in maternal plasma at 11-13 weeks of gestation.Semantic proximity Read ↗

Large-scale pre-diagnosis study of fetal RHD genotyping by PCR on plasma DNA from RhD-negative pregnant women.Semantic proximity Read ↗

Diagnostic accuracy of routine antenatal determination of fetal RHD status across gestation: population based cohort study.Semantic proximity Read ↗

Reliable test for prenatal prediction of fetal RhD type using maternal plasma from RhD negative women.Semantic proximity Read ↗

RHD genotyping from maternal plasma: guidelines and technical challenges.Semantic proximity Read ↗

Evaluation of an automated platform for non-invasive single-exon fetal RHD genotyping early in pregnancy.Semantic proximity Read ↗

Prenatal non-invasive foetal RHD genotyping: diagnostic accuracy of a test as a guide for appropriate administration of antenatal anti-D immunoprophylaxis.Semantic proximity Read ↗

Large-Scale Pre-Diagnosis Study of Fetal RHD Genotyping by PCR on Plasma DNA from RhD-Negative Pregnant WomenSemantic proximity Read ↗

Evaluation of prenatal RHD typing strategies on cell-free fetal DNA from maternal plasma.Semantic proximity Read ↗

Screening of RHD fetal genotype in RhD negative women.Semantic proximity Read ↗

Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood--a meta-analysis.Semantic proximity Read ↗

Investigation of discrepancies obtained during 15 years of non-invasive fetal RHD genotyping in apparent serologic RhD-negative pregnant women.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.